» Articles » PMID: 14769836

Eye-preservation Treatment of Retinoblastoma with Vitreous Seeding

Overview
Specialty Oncology
Date 2004 Feb 11
PMID 14769836
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma with vitreous seeding has been one of the most challenging conditions for eye-preservation therapy. Several modalities for treating vitreous seeding were reviewed in order to analyze the problems associated with them. External beam radiotherapy has been the most reliable method to treat vitreous seeding. However, recurrence after external beam radiotherapy needs other types of treatments to preserve the eyeballs. Due to the progress of investigations concerning retinoblastoma, chemotherapy has become the most promising method to cure not only recurrence but also primary tumors. Systemic chemotherapy can rarely cure vitreous seeding, but local chemotherapy using vitreous injections of melphalan can preserve about 50% of the eyeballs with vitreous seeding. Currently, animal experiments are being conducted to study the efficacy and safety of vitreous surgery combined with infusion of anticancer drugs for eradication of vitreous seeds and maintenance of visual function.

Citing Articles

Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances.

Kulbay M, Tuli N, Mazza M, Jaffer A, Juntipwong S, Marcotte E Biomedicines. 2025; 13(1).

PMID: 39857692 PMC: 11762644. DOI: 10.3390/biomedicines13010108.


New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy.

Zebret S, Hadiji M, Romano-deGea J, Bornet A, Ortiz D, Fadaei-Tirani F RSC Med Chem. 2024; 15(7):2300-2304.

PMID: 39026655 PMC: 11253858. DOI: 10.1039/d4md00211c.


The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma.

Muniyandi A, Jensen N, Devanathan N, Dimaras H, Corson T Invest Ophthalmol Vis Sci. 2024; 65(1):18.

PMID: 38180770 PMC: 10774694. DOI: 10.1167/iovs.65.1.18.


Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding.

Alahmadi G, Maktabi A, Sesma G, AlMesfer S Clin Ophthalmol. 2023; 17:1789-1800.

PMID: 37377999 PMC: 10292623. DOI: 10.2147/OPTH.S417370.


Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.

Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F Onco Targets Ther. 2022; 15:1545-1561.

PMID: 36579184 PMC: 9792108. DOI: 10.2147/OTT.S370878.